Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.
 

Advisory Committee

Crews- 100x100
Jennie R. Crews, MD, MMM, FACP
Medical Director, Research Integration and SCCA Network
Seattle Cancer Care Alliance
Associate Clinical Professor,University of Washington School of Medicine
Seattle, WA

Jennie R. Crews, MD, MMM, FACP, is medical director, Seattle Cancer Care Alliance Network; Medical Director, Research Integration at Seattle Cancer Care Alliance (SCCA); and associate professor of Medicine, University of Washington. Dr. Crews has more than 18 years of experience in oncology in academic, private practice, and hospital-based settings. Previously she served as the medical director for Cancer Services in the PeaceHealth Northwest Network, which includes St. Joseph Cancer Center in Bellingham, Washington; PeaceIsland Hospital on San Juan Island, Washington; and PeaceHealth Ketchikan, Alaska. She also served as the medical director of the Marion L. Shepard Cancer Center in Washington, N.C., and held appointments as a consulting associate in the Department of Medicine, Division of Medical Oncology and Transplantation at Duke, and as an affiliate associate professor in the Department of Medicine at East Carolina University.

Dr. Crews served as ACCC Treasurer (2013-2015), ACCC President-Elect (2015-2016), and ACCC President (2016-2017). She has served as the president of the North Carolina Oncology Association (NCOA) and as NCOA’s legislative liaison to the North Carolina General Assembly. She is on the Editorial Committee for the ACCC Oncology Drug Database, a reviewer for the Journal of Oncology Practice, and a member of the ASCO Practice Guidelines Implementation Network. She has been named to the Best Doctors in America since 2007.

Dr. Crews received her BS degree in Biology with highest honors from the University of North Carolina at Chapel Hill. She earned her MD from Duke University and completed training in internal medicine and oncology at Duke, where she served as assistant chief resident. She is a Fellow in the American College of Physicians and is board certified in internal medicine and medical oncology.

Shelley Fuld Nasso
Shelley Fuld Nasso, MPP
Chief Executive Officer
National Coalition for Cancer Survivorship

Shelley Fuld Nasso is chief executive officer of the National Coalition for Cancer Survivorship (NCCS), where she leads the public policy activities at a time of rapid and fundamental healthcare system change.

Prior to joining NCCS in 2012, Ms. Nasso served in leadership roles at Susan G. Komen, where she leveraged Komen’s grassroots network in Washington, D.C., and state capitals. There she built relationships with policymakers and partner organizations and led a team of staff and volunteers to influence state budgets and legislation. Under her direction, Komen successfully secured $80 million in state funding for cancer screening and treatment for uninsured and underinsured women.

Ms. Nasso and her team also expanded the Komen grassroots advocacy program from a pilot of seven affiliates to more than 100 affiliates across the country engaged in federal and state advocacy efforts. Formerly, she served as director of community philanthropy at The Dallas Foundation and held management positions at communications and technology enterprises.

Regina Jacob, MD, MSCE
Assistant Professor, Clinical Medicine;
Director, Social Determinants of Health Curriculum, Internal Medicine Residency Program
Lewis Katz School of Medicine at Temple University

Regina Jacob, MD, MSCE, is an assistant professor of Clinical Medicine at The Lewis Katz School of Medicine at Temple University in North Philadelphia.  She received her MD degree from The George Washington University in Washington, D.C., completed her internal medicine residency at Temple University Hospital, and earned a master’s degree in Clinical Epidemiology at The Weill Cornell Medical College of Cornell University in Manhattan, New York.

Dr. Jacob has two main research interests which both assess psychological adjustment and co-morbid medical conditions.  She conducted a study called Coping with Lymphoma to Enhance Adjustment and Reduce Stress, which assessed the psychological adjustments which may occur after a diagnosis of lymphoma.  She continues to grow her cancer survivorship expertise in education, designing curricula to educate internal medicine residents on how to appropriately tailor primary care for patients with a history of cancer. 

Her second research interest involves assessing co-morbid conditions that result from chronic and cumulative trauma exposure.  She is currently conducting a study called Trauma Alert! How Social Complexity Contributes to Medical Complexity, which assesses the prevalence of post-traumatic stress disorder (PTSD), adverse childhood experiences, depression, and co-morbidity in an underserved primary care population. While the effects of poverty on healthcare are known, there is still a large amount of work to be done with regards to how trauma associated with poverty results in negative health behaviors and subsequent poor medical and psychological outcomes.

Dr. Katy Tsai, MD
Katy K. Tsai, MD
Medical Oncologist and Clinical Instructor,
Division of Hematology and Oncology
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Dr. Katy K. Tsai is a medical oncologist who specializes in treating melanoma and other skin cancers.

In addition to caring for patients, Dr. Tsai conducts clinical trials with two of her colleagues in cutaneous oncology, Dr. Adil Daud and Dr. Alain Algazi, seeking new and better therapies for patients with advanced melanoma or head and neck cancers. She also has a long-standing research interest in quality of life and outcomes for patients receiving immunotherapy.

Dr. Tsai graduated with a degree in comparative literature from Brown University before earning her medical degree from Brown. She completed a residency in internal medicine at the University of North Carolina at Chapel Hill, followed by a fellowship in medical oncology at UCSF, where she served as chief fellow.

Tsai is a member of the American Society of Clinical Oncology.

 

Michelle Turner, NP
Michelle Turner, MS, CRNP
Senior Lead Nurse Practitioner, Thoracic Oncology
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD

Michelle Turner, MS, CRNP, is the Senior Lead Nurse Practitioner in Thoracic Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, where she also serves as an Advanced Practitioner and Program Coordinator for the Lung Cancer Urgent Care and Survivorship Clinics.

Ms. Turner has clinical expertise in thoracic, hematologic, and gastrointestinal malignancies, in addition to solid tumors, HIV, diabetes, pain management, and immuno-oncology. With more than 16 years of experience as an oncology nurse practitioner, she has worked with patients both on and off clinical trials, diagnosing and managing symptoms of disease and treatment. She also has served as a sub-investigator on several clinical trials. 

She is a member of the American Academy of Nurse Practitioners, the International Association for the Study of Lung Cancer, the International Thoracic Oncology Nursing Foundation. She also serves as Co-President of the Baltimore City Nurse Practitioner Group, for which she helps organize monthly educational meetings to discuss new and upcoming oncologic therapies for maintaining competency in the ever-changing landscape of medicine.

Ms. Turner received a bachelor’s degree in biological sciences from Wheaton College and a master’s of science degree from the Boston College Graduate School of Nursing. Prior to joining Johns Hopkins, Ms. Turner held positions at Dana-Farber Cancer Institute, Massachusetts General Hospital, the University of Maryland Medical Center, and the University of Maryland Greenebaum Comprehensive Cancer Center.

Our Supporter

BMS-330x80